Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

01-12-2020 | Amoxicillin | Research

Development of amoxicillin resistance in Escherichia coli after exposure to remnants of a non-related phagemid-containing E. coli: an exploratory study

Authors: Joep J. J. M. Stohr, Marjolein F. Q. Kluytmans-van den Bergh, Carlo J. M. M. Verhulst, John W. A. Rossen, Jan A. J. W. Kluytmans

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

Objective

To determine the effect of exposure to remnants of a phagemid-containing E. coli, killed by treatment with a propanol-based hand rub, on antimicrobial resistance in E. coli isolates.

Methods

An in vitro model was developed in which a clinical E. coli isolate (EUR1) was exposed to remnants of an E. coli K-12 strain containing a phagemid (pBS-E12) strain treated with Sterillium®. A series of 200 experiments was performed using this in vitro model. As a control, a series of 400 experiments was performed where the EUR1 was exposed either to the remnants of an E. coli K-12 strain (not containing a phagemid) (E12) treated with Sterillium® (n = 200) or to dried Sterillium® only (n = 200). The number of experiments that showed growth of an amoxicillin-resistant EUR1 isolate was evaluated in all three groups. An additional 48 experiments were performed in which a different clinical E. coli isolate (EUR2) was exposed to remnants of the pBS-E12 treated with Sterillium®. Whole-genome sequencing and phenotypic testing for AmpC beta-lactamase production was performed to investigate the mechanism behind this resistance development.

Results

In 22 (11.0%) of 200 experiments in which the EUR1 isolate was exposed to remnants of a pBS-E12 an amoxicillin-resistant mutant isolate was obtained, as opposed to only 2 (1.0%) of 200 experiments involving the exposure of the EUR1 to Sterillium® only (risk difference: 10.0%; 95% CI 5.4–14.6%)) and 1 (0.5%) of 200 experiments involving the exposure of the EUR1 isolate to the remnants of the phagemid-free E12 (risk difference: 10.5%; 95% CI 6.1–14.9%). In 1 (2.1%) of the 48 experiments in which the EUR2 isolate was exposed to remnants of a pBS-E12 an amoxicillin-resistant mutant isolate was obtained. The development of resistance in all experiments was due to mutations in the promoter/attenuator region of the chromosomal AmpC beta-lactamase (cAmpC) gene leading to cAmpC hyperproduction.

Conclusion

Exposure of an E. coli isolate to another phagemid-containing E. coli that was treated with propanol-based hand rub increased the development of amoxicillin resistance. Although phagemids are cloning vectors that are not present in clinical isolates, this finding may have implications for hand disinfection practices in healthcare facilities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bonnet R. Growing group of extended spectrum: the CTX-M enzymes. Antimicrob Agent Chemother. 2004;48(1):1–14.CrossRef Bonnet R. Growing group of extended spectrum: the CTX-M enzymes. Antimicrob Agent Chemother. 2004;48(1):1–14.CrossRef
3.
go back to reference Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high- risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28(3):565–91.PubMedPubMedCentralCrossRef Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high- risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28(3):565–91.PubMedPubMedCentralCrossRef
4.
go back to reference Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(s1):1–55.PubMedCrossRef Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(s1):1–55.PubMedCrossRef
5.
go back to reference Boyce J, Pittet D. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force. MMWR Recomm Rep. 2002;51:1–45.PubMed Boyce J, Pittet D. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force. MMWR Recomm Rep. 2002;51:1–45.PubMed
6.
go back to reference Kampf G, Ostermeyer C, Heeg P, Paulson D. Evaluation of two methods of determining the efficacies of two alcohol-based hand rubs for surgical hand antisepsis. Appl Environ Microbiol. 2006;72(6):3856–61.PubMedPubMedCentralCrossRef Kampf G, Ostermeyer C, Heeg P, Paulson D. Evaluation of two methods of determining the efficacies of two alcohol-based hand rubs for surgical hand antisepsis. Appl Environ Microbiol. 2006;72(6):3856–61.PubMedPubMedCentralCrossRef
7.
go back to reference Kampf G, Kapella M. Suitability of Sterillium gel™ for surgical hand disinfection. J Hosp Infect. 2003;54(3):222–5.PubMedCrossRef Kampf G, Kapella M. Suitability of Sterillium gel™ for surgical hand disinfection. J Hosp Infect. 2003;54(3):222–5.PubMedCrossRef
8.
go back to reference Kampf G, Ostermeyer C, Heeg P. Surgical hand disinfection with a propanol-based hand rub: equivalence of shorter application times. J Hosp Infect. 2005;59(4):304–10.PubMedCrossRef Kampf G, Ostermeyer C, Heeg P. Surgical hand disinfection with a propanol-based hand rub: equivalence of shorter application times. J Hosp Infect. 2005;59(4):304–10.PubMedCrossRef
9.
go back to reference Kramer A, Rudolph P, Kampf G, Pittet D. Limited efficacy of alcohol-based hand gels. Lancet. 2002;359(9316):1489–90.PubMedCrossRef Kramer A, Rudolph P, Kampf G, Pittet D. Limited efficacy of alcohol-based hand gels. Lancet. 2002;359(9316):1489–90.PubMedCrossRef
10.
go back to reference Mao D, Luo Y, Mathieu J, Wang Q, Feng L, Mu Q, et al. Persistence of extracellular DNA in river sediment facilitates antibiotic resistance gene propagation. Environ Sci Technol. 2014;48(1):71–8.PubMedCrossRef Mao D, Luo Y, Mathieu J, Wang Q, Feng L, Mu Q, et al. Persistence of extracellular DNA in river sediment facilitates antibiotic resistance gene propagation. Environ Sci Technol. 2014;48(1):71–8.PubMedCrossRef
11.
go back to reference Nielsen KM, Smalla K, Van Elsas JD. Natural transformation of Acinetobacter sp. strain BD413 with cell lysates of Acinetobacter sp., Pseudomonas fluorescens, and Burkholderia cepacia in soil microcosms. Appl Environ Microbiol. 2000;66(1):206–12.PubMedPubMedCentralCrossRef Nielsen KM, Smalla K, Van Elsas JD. Natural transformation of Acinetobacter sp. strain BD413 with cell lysates of Acinetobacter sp., Pseudomonas fluorescens, and Burkholderia cepacia in soil microcosms. Appl Environ Microbiol. 2000;66(1):206–12.PubMedPubMedCentralCrossRef
12.
go back to reference Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY, et al. High-level β-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003;47(7):2169–78.PubMedPubMedCentralCrossRef Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY, et al. High-level β-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003;47(7):2169–78.PubMedPubMedCentralCrossRef
13.
go back to reference Bae J, Oh E, Jeon B. Enhanced transmission of antibiotic resistance in Campylobacter jejuni biofilms by natural transformation. Antimicrob Agents Chemother. 2014;58(12):7573–5.PubMedPubMedCentralCrossRef Bae J, Oh E, Jeon B. Enhanced transmission of antibiotic resistance in Campylobacter jejuni biofilms by natural transformation. Antimicrob Agents Chemother. 2014;58(12):7573–5.PubMedPubMedCentralCrossRef
14.
go back to reference Trzciński K, Thompson CM, Lipsitch M. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol. 2004;186(11):3447–52.PubMedPubMedCentralCrossRef Trzciński K, Thompson CM, Lipsitch M. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol. 2004;186(11):3447–52.PubMedPubMedCentralCrossRef
15.
go back to reference Johnston C, Martin B, Fichant G, Polard P, Claverys J-P. Bacterial transformation: distribution, shared mechanisms and divergent control. Nat Rev Microbiol. 2014;12(3):181–96.PubMedCrossRef Johnston C, Martin B, Fichant G, Polard P, Claverys J-P. Bacterial transformation: distribution, shared mechanisms and divergent control. Nat Rev Microbiol. 2014;12(3):181–96.PubMedCrossRef
16.
go back to reference Domingues S, Harms K, Fricke WF, Johnsen PJ, da Silva GJ, Nielsen KM. Natural Transformation Facilitates Transfer of Transposons, Integrons and Gene Cassettes between Bacterial Species. PLoS Pathog. 2012;8(8):e1002837.PubMedPubMedCentralCrossRef Domingues S, Harms K, Fricke WF, Johnsen PJ, da Silva GJ, Nielsen KM. Natural Transformation Facilitates Transfer of Transposons, Integrons and Gene Cassettes between Bacterial Species. PLoS Pathog. 2012;8(8):e1002837.PubMedPubMedCentralCrossRef
17.
go back to reference Sun D, Zhang Y, Mei Y, Jiang H, Xie Z, Liu H, et al. Escherichia coli is naturally transformable in a novel transformation system. FEMS Microbiol Lett. 2006;265(2):249–55.PubMedCrossRef Sun D, Zhang Y, Mei Y, Jiang H, Xie Z, Liu H, et al. Escherichia coli is naturally transformable in a novel transformation system. FEMS Microbiol Lett. 2006;265(2):249–55.PubMedCrossRef
18.
go back to reference Baur B, Hanselmann K, Schlimme W, Jenni B. Genetic transformation in freshwater: Escherichia coli is able to develop natural competence. Appl Environ Microbiol. 1996;62(10):3673–8.PubMedPubMedCentralCrossRef Baur B, Hanselmann K, Schlimme W, Jenni B. Genetic transformation in freshwater: Escherichia coli is able to develop natural competence. Appl Environ Microbiol. 1996;62(10):3673–8.PubMedPubMedCentralCrossRef
19.
go back to reference Maeda S, Ito M, Ando T, Ishimoto Y, Fujisawa Y, Takahashi H, et al. Horizontal transfer of nonconjugative plasmids ina colony biofilm of Escherichia coli. FEMS Microbiol Lett. 2006;255(1):115–20.PubMedCrossRef Maeda S, Ito M, Ando T, Ishimoto Y, Fujisawa Y, Takahashi H, et al. Horizontal transfer of nonconjugative plasmids ina colony biofilm of Escherichia coli. FEMS Microbiol Lett. 2006;255(1):115–20.PubMedCrossRef
20.
go back to reference Maeda S, Sawamura A, Matsuda A. Transformation of colonial Escherichia coli on solid media. FEMS Microbiol Lett. 2004;236(1):61–4.PubMedCrossRef Maeda S, Sawamura A, Matsuda A. Transformation of colonial Escherichia coli on solid media. FEMS Microbiol Lett. 2004;236(1):61–4.PubMedCrossRef
21.
go back to reference Etchuuya R, Ito M, Kitano S, Shigi F, Sobue R, Maeda S. Cell-to-cell transformation in Escherichia coli: a novel type of natural transformation involving cell-derived DNA and a putative promoting pheromone. PLoS One. 2011;6(1):e16355.PubMedPubMedCentralCrossRef Etchuuya R, Ito M, Kitano S, Shigi F, Sobue R, Maeda S. Cell-to-cell transformation in Escherichia coli: a novel type of natural transformation involving cell-derived DNA and a putative promoting pheromone. PLoS One. 2011;6(1):e16355.PubMedPubMedCentralCrossRef
22.
go back to reference Johnson L, Horsman SR, Charron-Mazenod L, Turnbull AL, Mulcahy H, Surette MG, et al. Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol. 2013;13(1):1 Available from: BMC Microbiology.CrossRef Johnson L, Horsman SR, Charron-Mazenod L, Turnbull AL, Mulcahy H, Surette MG, et al. Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol. 2013;13(1):1 Available from: BMC Microbiology.CrossRef
23.
go back to reference Lewenza S. Extracellular DNA-induced antimicrobial peptide resistance mechanisms in Pseudomonas aeruginosa. Front Microbiol. 2013;4(FEB):1–6. Lewenza S. Extracellular DNA-induced antimicrobial peptide resistance mechanisms in Pseudomonas aeruginosa. Front Microbiol. 2013;4(FEB):1–6.
24.
go back to reference The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1, 2018. http://www.eucast.org. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1, 2018. http://​www.​eucast.​org.
25.
go back to reference Lee J, Choi J, Kim H. Determination of hand surface area by sex and body shape using alginate. J Physiol Anthropol. 2007;26(4):475–83.PubMedCrossRef Lee J, Choi J, Kim H. Determination of hand surface area by sex and body shape using alginate. J Physiol Anthropol. 2007;26(4):475–83.PubMedCrossRef
26.
go back to reference Girard R, Aupee M, Erb M, Bettinger A, Jouve A. Hand rub dose needed for a single disinfection varies according to product: a bias in benchmarking using indirect hand hygiene indicator. J Epidemiol Glob Health. 2012;2(4):193–8.PubMedCrossRefPubMedCentral Girard R, Aupee M, Erb M, Bettinger A, Jouve A. Hand rub dose needed for a single disinfection varies according to product: a bias in benchmarking using indirect hand hygiene indicator. J Epidemiol Glob Health. 2012;2(4):193–8.PubMedCrossRefPubMedCentral
27.
go back to reference de Velde F, de Winter BCM, Koch BCP, van Gelder T, Mouton JW. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints. J Antimicrob Chemother. 2016;71(10):2909–17.PubMedCrossRef de Velde F, de Winter BCM, Koch BCP, van Gelder T, Mouton JW. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints. J Antimicrob Chemother. 2016;71(10):2909–17.PubMedCrossRef
28.
go back to reference Zankari E, Allesøe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72(10):2764–8.PubMedPubMedCentralCrossRef Zankari E, Allesøe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72(10):2764–8.PubMedPubMedCentralCrossRef
29.
go back to reference Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–4.PubMedPubMedCentralCrossRef Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67(11):2640–4.PubMedPubMedCentralCrossRef
30.
go back to reference Kluytmans-van den Bergh MFQ, Rossen JWA, Bruijning-Verhagen PCJ, Bonten MJM, Friedrich AW, Vandenbroucke-Grauls CMJE, et al. Whole-genome multilocus sequence typing of extended-Spectrum-Beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2016;54(12):2919–27.PubMedPubMedCentralCrossRef Kluytmans-van den Bergh MFQ, Rossen JWA, Bruijning-Verhagen PCJ, Bonten MJM, Friedrich AW, Vandenbroucke-Grauls CMJE, et al. Whole-genome multilocus sequence typing of extended-Spectrum-Beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2016;54(12):2919–27.PubMedPubMedCentralCrossRef
31.
go back to reference Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, et al. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol Lett. 2007;270(2):265–71.PubMedCrossRef Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, et al. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol Lett. 2007;270(2):265–71.PubMedCrossRef
32.
go back to reference Firmino N, Goldsmith J-M, Morin A. Ampicillin resistance is increased in Escherichia coli K12 relA and spoT mutants but sub-inhibitory pretreatment does not induce adaptive resistance. J Exp Microbiol Immunol. 2013;17(April):34–9. Firmino N, Goldsmith J-M, Morin A. Ampicillin resistance is increased in Escherichia coli K12 relA and spoT mutants but sub-inhibitory pretreatment does not induce adaptive resistance. J Exp Microbiol Immunol. 2013;17(April):34–9.
33.
go back to reference Baharoglu Z, Mazel D. Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance. Antimicrob Agents Chemother. 2011;55(5):2438–41.PubMedPubMedCentralCrossRef Baharoglu Z, Mazel D. Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance. Antimicrob Agents Chemother. 2011;55(5):2438–41.PubMedPubMedCentralCrossRef
34.
go back to reference Eliopoulos GM, Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis. 2003;37(9):1201–9.CrossRef Eliopoulos GM, Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis. 2003;37(9):1201–9.CrossRef
35.
go back to reference Petrosino JF, Galhardo RS, Morales LD, Rosenberg SM. Stress-induced β-lactam antibiotic resistance mutation and sequences of stationary-phase mutations in the Escherichia coli chromosome. J Bacteriol. 2009;191(19):5881–9.PubMedPubMedCentralCrossRef Petrosino JF, Galhardo RS, Morales LD, Rosenberg SM. Stress-induced β-lactam antibiotic resistance mutation and sequences of stationary-phase mutations in the Escherichia coli chromosome. J Bacteriol. 2009;191(19):5881–9.PubMedPubMedCentralCrossRef
36.
go back to reference Fruci M, Poole K. Bacterial stress responses as determinants of antimicrobial resistance. In: Stress and environmental regulation of gene expression and adaptation in Bacteria. Hoboken: Wiley; 2016. p. 115–36.CrossRef Fruci M, Poole K. Bacterial stress responses as determinants of antimicrobial resistance. In: Stress and environmental regulation of gene expression and adaptation in Bacteria. Hoboken: Wiley; 2016. p. 115–36.CrossRef
37.
go back to reference Nishino K, Yamasaki S, Hayashi-Nishino M, Yamaguchi A. Effect of NlpE overproduction on multidrug resistance in Escherichia coli. Antimicrob Agents Chemother. 2010;54(5):2239–43.PubMedPubMedCentralCrossRef Nishino K, Yamasaki S, Hayashi-Nishino M, Yamaguchi A. Effect of NlpE overproduction on multidrug resistance in Escherichia coli. Antimicrob Agents Chemother. 2010;54(5):2239–43.PubMedPubMedCentralCrossRef
38.
go back to reference Raivio TL, Leblanc SKD, Price NL. The Escherichia coli Cpx envelope stress response regulates genes of diverse function that impact antibiotic resistance and membrane integrity. J Bacteriol. 2013;195(12):2755–67.PubMedPubMedCentralCrossRef Raivio TL, Leblanc SKD, Price NL. The Escherichia coli Cpx envelope stress response regulates genes of diverse function that impact antibiotic resistance and membrane integrity. J Bacteriol. 2013;195(12):2755–67.PubMedPubMedCentralCrossRef
39.
go back to reference Kampf G. Lack of antimicrobial efficacy of mecetronium etilsulfate in propanol-based hand rubs for surgical hand disinfection. J Hosp Infect. 2017;96(2):189–91.PubMedCrossRef Kampf G. Lack of antimicrobial efficacy of mecetronium etilsulfate in propanol-based hand rubs for surgical hand disinfection. J Hosp Infect. 2017;96(2):189–91.PubMedCrossRef
40.
go back to reference Kampf G, Kramer A, Suchomel M. Lack of sustained efficacy for alcohol-based surgical hand rubs containing ‘residual active ingredients’ according to EN 12791. J Hosp Infect. 2017;95(2):163–8.PubMedCrossRef Kampf G, Kramer A, Suchomel M. Lack of sustained efficacy for alcohol-based surgical hand rubs containing ‘residual active ingredients’ according to EN 12791. J Hosp Infect. 2017;95(2):163–8.PubMedCrossRef
41.
go back to reference van der Horst MA, Schuurmans JM, Smid MC, Koenders BB, ter Kuile BH. De novo Acquisition of Resistance to three antibiotics by Escherichia coli. Microb Drug Resist. 2011;17(2):141–7.PubMedCrossRef van der Horst MA, Schuurmans JM, Smid MC, Koenders BB, ter Kuile BH. De novo Acquisition of Resistance to three antibiotics by Escherichia coli. Microb Drug Resist. 2011;17(2):141–7.PubMedCrossRef
42.
go back to reference Händel N, Schuurmans JM, Feng Y, Brul S, ter Kuile BH. Interaction between mutations and regulation of gene expression during development of De novo antibiotic resistance. Antimicrob Agents Chemother. 2014;58(8):4371–9.PubMedPubMedCentralCrossRef Händel N, Schuurmans JM, Feng Y, Brul S, ter Kuile BH. Interaction between mutations and regulation of gene expression during development of De novo antibiotic resistance. Antimicrob Agents Chemother. 2014;58(8):4371–9.PubMedPubMedCentralCrossRef
43.
go back to reference Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, et al. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother. 2005;49(1):358–65.PubMedPubMedCentralCrossRef Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, et al. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother. 2005;49(1):358–65.PubMedPubMedCentralCrossRef
44.
go back to reference Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell. 2010;37(3):311–20.PubMedPubMedCentralCrossRef Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell. 2010;37(3):311–20.PubMedPubMedCentralCrossRef
45.
go back to reference Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis. 2004;39(5):702–9.PubMedCrossRef Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis. 2004;39(5):702–9.PubMedCrossRef
Metadata
Title
Development of amoxicillin resistance in Escherichia coli after exposure to remnants of a non-related phagemid-containing E. coli: an exploratory study
Authors
Joep J. J. M. Stohr
Marjolein F. Q. Kluytmans-van den Bergh
Carlo J. M. M. Verhulst
John W. A. Rossen
Jan A. J. W. Kluytmans
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Amoxicillin
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-020-00708-7

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.